Key | % Net Assets |
---|---|
4½% Treasury Gilt 2013 | 11.5% |
Roche Finance Europe 5.375% | 2.0% |
National Grid Electricity 2.983% IDX-LKD | 1.8% |
GlaxoSmithKline | 1.8% |
Other | 82.9% |
Name | % Net Assets |
---|---|
4½% Treasury Gilt 2013 | 11.5% |
Roche Finance Europe 5.375% | 2.0% |
National Grid Electricity 2.983% IDX-LKD | 1.8% |
GlaxoSmithKline | 1.8% |
Singapore Petroleum Co. | 1.4% |
Huadian Power International Corp. | 1.4% |
General Accident plc 7 7/8% | 1.3% |
Scud Group | 1.3% |
Marks & Spencer 5.625% 2014 | 1.2% |
China Shineway Pharmaceutical Group | 1.2% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 454.80p |
Currency | GBP |
Change | -1.00p |
% | -0.22% |
YTD change | 16.40p |
YTD % | 3.74% |
Fund Inception | 17/11/1994 |
---|---|
Fund Manager | ROB HEPWORTH |
TER | - |
Minimum Investment | |
---|---|
Initial | £200 |
Additional | n/a |
Savings | £25 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.20 |
You are here: research